In last trading session, Prothena Corporation plc (NASDAQ:PRTA) saw 0.43 million shares changing hands with its beta currently measuring 0.03. Company’s recent per share price level of $13.74 trading at -$0.33 or -2.35% at ring of the bell on the day assigns it a market valuation of $739.59M. That closing price of PRTA’s stock is at a discount of -107.64% from its 52-week high price of $28.53 and is indicating a premium of 14.85% from its 52-week low price of $11.70. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.45 million shares which gives us an average trading volume of 503.43K if we extend that period to 3-months.
For Prothena Corporation plc (PRTA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 15 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Prothena Corporation plc (NASDAQ:PRTA) trade information
Upright in the red during last session for losing -2.35%, in the last five days PRTA remained trading in the red while hitting it’s week-highest on Monday, 03/10/25 when the stock touched $13.74 price level, adding 9.25% to its value on the day. Prothena Corporation plc’s shares saw a change of -0.79% in year-to-date performance and have moved -10.02% in past 5-day. Prothena Corporation plc (NASDAQ:PRTA) showed a performance of -0.58% in past 30-days. Number of shares sold short was 9.13 million shares which calculate 26.28 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 56 to the stock, which implies a rise of 75.46% to its current value. Analysts have been projecting 24 as a low price target for the stock while placing it at a high target of 98. It follows that stock’s current price would drop -74.67% in reaching the projected high whereas dropping to the targeted low would mean a loss of -74.67% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -3.15% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -58.69% while estimates for its earnings growth in next 5 years are of -17.79%.
Prothena Corporation plc (NASDAQ:PRTA)’s Major holders
Insiders are in possession of 19.02% of company’s total shares while institution are holding 102.51 percent of that, with stock having share float percentage of 126.59%. Investors also watch the number of corporate investors in a company very closely, which is 102.51% institutions for Prothena Corporation plc that are currently holding shares of the company. ECOR1 CAPITAL, LLC is the top institutional holder at PRTA for having 11.58 million shares of worth $239.1 million. And as of 2024-06-30, it was holding 21.5453 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 8.07 million shares on 2024-06-30. The number of shares represents firm’s hold over 15.016 of outstanding shares, having a total worth of $166.48 million.
On the other hand, Vanguard Specialized-Health Care Fund and Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 4.5 shares of worth $61.89 million or 8.37% of the total outstanding shares. The later fund manager was in possession of 2.32 shares on Dec 31, 2024 , making its stake of worth around $31.91 million in the company or a holder of 4.31% of company’s stock.
